"Designing Growth Strategies is in our DNA"

Stomach Cancer Treatment Market Size, Share & Industry Analysis, By Drug Type (Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, and Others), By Disease Indication (Gastric Adenocarcinoma, Gastrointestinal Stromal Tumor (GIST)), By Route of Administration (Oral and Parenteral) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Regional Forecast, 2019-2032

Last Updated: July 01, 2024 | Format: PDF | Report ID: FBI102094

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Stomach Cancer – For Key Countries
    2. Regulatory Scenario - For Key Countries/Regions
    3. Reimbursement Scenario - For Key Countries/Regions
    4. New Product Launches
    5. Key Industry Developments - Mergers, Acquisitions and Partnerships
  5. Global Stomach Cancer/Gastric Cancer Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
      2. Human Epidermal Growth Factor Receptor (HER2) Antagonists
      3. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Gastric Adenocarcinoma
      2. Gastrointestinal Stromal Tumor (GIST)
      3. Gastric Neuroendocrine Tumor (gNET)
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Stomach Cancer/Gastric Cancer Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
      2. Human Epidermal Growth Factor Receptor (HER2) Antagonists
      3. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
      4. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Gastric Adenocarcinoma
      2. Gastrointestinal Stromal Tumor (GIST)
      3. Gastric Neuroendocrine Tumor (gNET)
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Stomach Cancer/Gastric Cancer Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
      2. Human Epidermal Growth Factor Receptor (HER2) Antagonists
      3. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Gastric Adenocarcinoma
      2. Gastrointestinal Stromal Tumor (GIST)
      3. Gastric Neuroendocrine Tumor (gNET)
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
      2. Human Epidermal Growth Factor Receptor (HER2) Antagonists
      3. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Gastric Adenocarcinoma
      2. Gastrointestinal Stromal Tumor (GIST)
      3. Gastric Neuroendocrine Tumor (gNET)
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Stomach Cancer/Gastric Cancer Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
      2. Human Epidermal Growth Factor Receptor (HER2) Antagonists
      3. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Gastric Adenocarcinoma
      2. Gastrointestinal Stromal Tumor (GIST)
      3. Gastric Neuroendocrine Tumor (gNET)
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Countries/ Sub regions
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Programmed Cell Death Protein 1 (PD-1) Inhibitors
      2. Human Epidermal Growth Factor Receptor (HER2) Antagonists
      3. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Gastric Adenocarcinoma
      2. Gastrointestinal Stromal Tumor (GIST)
      3. Gastric Neuroendocrine Tumor (gNET)
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    6. Market Analysis, Insights and Forecast – By Countries/ Sub region
      1. South Africa
      2. GCC
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Company Profiles (Overview, Drug Types & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Eli Lilly and Company
        1. Overview,
        2. Drug Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. F. Hoffmann-La Roche Ltd.
        1. Overview,
        2. Drug Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Merck & Co., Inc.
        1. Overview,
        2. Drug Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Novartis AG
        1. Overview,
        2. Drug Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Bayer AG
        1. Overview,
        2. Drug Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Celltrion Inc.
        1. Overview,
        2. Drug Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Bristol-Myers Squibb Company
        1. Overview,
        2. Drug Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. TAIHO PHARMACEUTICAL CO., LTD.
        1. Overview,
        2. Drug Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Ipsen Pharma
        1. Overview,
        2. Drug Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Jiangsu Hengrui Medicine Co., Ltd
        1. Overview,
        2. Drug Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability).
      11. Other Prominent Players
        1. Overview,
        2. Drug Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Stomach Cancer/Gastric Cancer Treatment Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Drug Type, 2018 & 2026

Figure 3:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Programmed Cell Death Protein 1 (PD-1) Inhibitors, 2015-2026

Figure 4:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Human Epidermal Growth Factor Receptor (HER2) Antagonists, 2015-2026

Figure 5:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists, 2015-2026

Figure 6:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 7:  Global Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Disease Indication, 2018 & 2026

Figure 8:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Gastric Adenocarcinoma, 2015-2026

Figure 9:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Gastrointestinal Stromal Tumor (GIST), 2015-2026

Figure 10:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Gastric Neuroendocrine Tumors (gNET), 2015-2026

Figure 11:  Global Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Route of Administration, 2018 & 2026

Figure 12:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Oral, 2015-2026

Figure 13:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Parenteral, 2015-2026

Figure 14:  Global Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 15:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Hospital Pharmacy, 2015-2026

Figure 16:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Retail Pharmacy, 2015-2026

Figure 17:  Global Stomach Cancer/Gastric Cancer Treatment Market Forecast (US$ Mn), by Online Pharmacy, 2015-2026

Figure 18:  Global Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Region, 2018 & 2026

Figure 19:  North America Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Drug Type, 2018 & 2026

Figure 20:  North America Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Drug Type, 2018

Figure 21:  North America Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 22:  North America Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Disease Indication, 2018

Figure 23:  North America Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 24:  North America Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Route of Administration, 2018

Figure 25:  North America Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 26:  North America Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 27:  North America Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), By Country, 2018 & 2026

Figure 28:  North America Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), By Country, 2018

Figure 29:  Europe Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Drug Type, 2018 & 2026

Figure 30:  Europe Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Drug Type, 2018

Figure 31:  Europe Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 32:  Europe Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Disease Indication, 2018

Figure 33:  Europe Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 34:  Europe Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Route of Administration, 2018

Figure 35:  Europe Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 36:  Europe Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 37:  Europe Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 38:  Europe Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 39:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Drug Type, 2018 & 2026

Figure 40:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Drug Type, 2018

Figure 41:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 42:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Disease Indication, 2018

Figure 43:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 44:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Route of Administration, 2018

Figure 45:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 46:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 47:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 48:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 49:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Drug Type, 2018 & 2026

Figure 50:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Drug Type, 2018

Figure 51:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 52:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Disease Indication, 2018

Figure 53:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 54:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Route of Administration, 2018

Figure 55:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 56:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 57:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 58:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 59:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Drug Type, 2018 & 2026

Figure 60:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Drug Type, 2018

Figure 61:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 62:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Disease Indication, 2018

Figure 63:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 64:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Route of Administration, 2018

Figure 65:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 66:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 67:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 68:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 69:  Global Stomach Cancer/Gastric Cancer Treatment Market Share (%), By Company, 2018

Table 1:  Global Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Drug Type, 2015–2026

Table 2:  Global Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015–2026

Table 3:  Global Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015–2026

Table 4:  Global Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 5:  Global Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 6:  North America Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Drug Type, 2015-2026

Table 7:  North America Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 8:  North America Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 9:  North America Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 10:  North America Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country, 2015-2026

Table 11:  Europe Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Drug Type, 2015-2026

Table 12:  Europe Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 13:  Europe Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 14:  Europe Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 15:  Europe Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/ Sub-region, 2015-2026

Table 16:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Drug Type, 2015-2026

Table 17:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 18:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 19:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Asia Pacific Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/ Sub-region, 2015-2026

Table 21:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Drug Type, 2015-2026

Table 22:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 23:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 24:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 25:  Latin America Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/ Sub-region, 2015-2026

Table 26:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Drug Type, 2015-2026

Table 27:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 28:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 29:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 30:  Middle East & Africa Stomach Cancer/Gastric Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/ Sub-region, 2015-2026

  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X